IL5 and asthma: Furthermore, sputum total IgE may also serve as a potential biomarker for guiding anti‐IL‐5 therapy in patients with severe asthma, with higher levels of sputum total IgE possibly predicting better responses to anti‐IL‐5 therapy.43